March 24, 2011

Bristol-Myers Squibb said its late-stage clinical trial for a cancer treatment, which currently is under review by the Food and Drug Administration, achieved its primary endpoint.

August 17, 2010

The Food and Drug Administration has agreed to expedite review of an investigational treatment for...

June 21, 2010

Cases of the potentially deadly skin cancer melanoma are expected to almost double before the...